16 Mai 2018 Jahr - FDA approved Lucemyra (lofexidine hydrochloride), the first non-opioid treatment for the mitigation of withdrawal symptoms associated with abrupt discontinuation of opioids.

Zugefügt zum Band der Zeit:

13 Nov 2018

0

0

328

Opioids and the FDA

Datum: